NGNE

Neurogene Inc. develops gene therapies aimed at treating rare neurological diseases. The company focuses on advancing its gene therapy programs through collaboration with internal and external experts, emphasizing innovation and scientific rigor. Neurogene's mission is to transform devastating conditions into treatable ones, improving the lives of patients and their families. It operates in the biotechnology sector, specifically targeting genetic medicine.